HIGHLIGHTS
- who: Yuying Wang and colleagues from the Department of Gastrointestinal Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China have published the article: A Single Strain of Lactobacillus (CGMCC 21661) Exhibits Stable Glucose- and Lipid-Lowering Effects by Regulating Gut Microbiota, in the Journal: Nutrients 2023, 670 of 26/01/2023
- what: The experiments verified that the dominant strains selected in this study have a significant role in treating T2D, lowering glucose levels, lowering lipids, and improving inflammation. The experiments described in this paper showed that, following bacterial transplantation, mice weight reduced to a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.